Life Spine received FDA 510(k) clearance for its VersaLift Expandable Interbody System, a device designed for transforaminal lumbar interbody fusion and posterior lumbar interbody fusion procedures.
The system features a 6-millimeter starting height, which is among the smallest available for a TLIF expandable interbody implant. It is approved in 8-, 10- and 12-millimeter widths and offers up to 15 degrees of lordotic correction, according to a June 23 news release from the company.
VersaLift is designed to support minimally invasive spine procedures by allowing insertion through constrained anatomy while reducing tissue disruption and nerve retraction. The implant also provides controlled in-situ expansion intended to preserve implant length during deployment while restoring disc height and supporting indirect neural decompression.
The system includes streamlined instrumentation designed to help surgeons achieve alignment and procedural goals while maintaining a simplified workflow, according to the release.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
